BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28167668)

  • 1. Myeloid Cell-Specific Knockout of NFI-A Improves Sepsis Survival.
    McPeak MB; Youssef D; Williams DA; Pritchett C; Yao ZQ; McCall CE; El Gazzar M
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis.
    Dai J; Kumbhare A; Williams DA; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Innate Immun; 2018 Jan; 24(1):54-65. PubMed ID: 29172874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFI-A disrupts myeloid cell differentiation and maturation in septic mice.
    McClure C; Ali E; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2016 Jan; 99(1):201-11. PubMed ID: 26259914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis.
    McClure C; Brudecki L; Ferguson DA; Yao ZQ; Moorman JP; McCall CE; El Gazzar M
    Infect Immun; 2014 Sep; 82(9):3816-25. PubMed ID: 24980967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontline Science: Myeloid cell-specific deletion of Cebpb decreases sepsis-induced immunosuppression in mice.
    McPeak MB; Youssef D; Williams DA; Pritchett CL; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2017 Aug; 102(2):191-200. PubMed ID: 28476751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of C/EBPβ in myeloid progenitors during sepsis promotes immunosuppression.
    Dai J; Kumbhare A; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Mol Immunol; 2017 Nov; 91():165-172. PubMed ID: 28934717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.
    Alkhateeb T; Kumbhare A; Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Mol Immunol; 2019 Aug; 112():72-81. PubMed ID: 31078118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HuR promotes miRNA-mediated upregulation of NFI-A protein expression in MDSCs during murine sepsis.
    Bah I; Alkhateeb T; Kumbhare A; Youssef D; Yao ZQ; Hawkin GA; McCall CE; El Gazzar M
    Mol Immunol; 2020 Jul; 123():97-105. PubMed ID: 32474254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 induces an immune repressor pathway in sepsis by promoting S100A9 nuclear localization and MDSC development.
    Bah I; Kumbhare A; Nguyen L; McCall CE; El Gazzar M
    Cell Immunol; 2018 Oct; 332():32-38. PubMed ID: 30025864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-Derived Suppressor Cells in Sepsis.
    Schrijver IT; Théroude C; Roger T
    Front Immunol; 2019; 10():327. PubMed ID: 30873175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
    Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
    Front Immunol; 2020; 11():1299. PubMed ID: 32719675
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
    Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
    Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated NKT cells facilitated functional switch of myeloid-derived suppressor cells at inflammation sites in fulminant hepatitis mice.
    Wu D; Shi Y; Wang C; Chen H; Liu Q; Liu J; Zhang L; Wu Y; Xia D
    Immunobiology; 2017 Feb; 222(2):440-449. PubMed ID: 27523745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases.
    Janols H; Bergenfelz C; Allaoui R; Larsson AM; Rydén L; Björnsson S; Janciauskiene S; Wullt M; Bredberg A; Leandersson K
    J Leukoc Biol; 2014 Nov; 96(5):685-93. PubMed ID: 24929004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of myeloid-derived suppressor cells in esophageal cancer patients is associated with the complication of sepsis.
    Xu J; Peng Y; Yang M; Guo N; Liu H; Gao H; Niu F; Wang R; Wang C; Yu K
    Biomed Pharmacother; 2020 May; 125():109864. PubMed ID: 32007915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
    Abrams SI; Netherby CS; Twum DY; Messmer MN
    J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-150 inhibits myeloid-derived suppressor cells proliferation and function through negative regulation of ARG-1 in sepsis.
    Liu Q; Wang Y; Zheng Q; Dong X; Xie Z; Panayi A; Bai X; Li Z
    Life Sci; 2021 Aug; 278():119626. PubMed ID: 34004247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock.
    Mathias B; Delmas AL; Ozrazgat-Baslanti T; Vanzant EL; Szpila BE; Mohr AM; Moore FA; Brakenridge SC; Brumback BA; Moldawer LL; Efron PA;
    Ann Surg; 2017 Apr; 265(4):827-834. PubMed ID: 27163951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α-Deficiency in Myeloid Cells Leads to a Disturbed Accumulation of Myeloid Derived Suppressor Cells (MDSC) During Pregnancy and to an Increased Abortion Rate in Mice.
    Köstlin-Gille N; Dietz S; Schwarz J; Spring B; Pauluschke-Fröhlich J; Poets CF; Gille C
    Front Immunol; 2019; 10():161. PubMed ID: 30804946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
    Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
    Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.